AbbVie Biogen gets go-ahead for EU Humira launch in October But deal with Samsung prevents US launch until mid-2023
Patients Notorious 'Pharma Bro' Shkreli jailed for fraud Martin Shkreli, the pharma entrepreneur who became notorious in 2015 for hiking the price of a lifesaving drug, has been sentenced to seven years in prison for fraud.
News US judge overturns Gilead $2.54bn patent infringement ruling Federal judge throws out Merck's patent claim against Gilead
News Greece to probe claims that Novartis bribed former leaders Scandal could be biggest in country's history, says politician
News Concordia hiked drug price by 6,000%, says UK watchdog CMA provisionally finds Concordia overpriced thyroid drug.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
